3 Growth Stocks With High Insider Ownership And Earnings Up To 55%

Simply Wall St.
2024-10-22

As global markets navigate a complex landscape marked by interest rate adjustments and sector-specific shifts, the U.S. indices have shown resilience with notable performances in mid-cap and small-cap segments. Amidst these developments, identifying growth stocks with high insider ownership can be particularly appealing, as such companies often demonstrate strong alignment between management and shareholder interests, potentially enhancing their capacity for sustained growth in fluctuating market conditions.

Top 10 Growth Companies With High Insider Ownership

Name Insider Ownership Earnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) 11.9% 21.1%
Atlas Energy Solutions (NYSE:AESI) 29.1% 41.9%
Archean Chemical Industries (NSEI:ACI) 22.9% 34%
Kirloskar Pneumatic (BSE:505283) 30.3% 30.1%
Clinuvel Pharmaceuticals (ASX:CUV) 10.4% 27.4%
Laopu Gold (SEHK:6181) 36.4% 33.2%
Medley (TSE:4480) 34% 30.4%
KebNi (OM:KEBNI B) 36.3% 86.1%
EHang Holdings (NasdaqGM:EH) 32.8% 81.4%
Credo Technology Group Holding (NasdaqGS:CRDO) 13.9% 95%

Click here to see the full list of 1486 stocks from our Fast Growing Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

Pharma Mar

Simply Wall St Growth Rating: ★★★★★☆

Overview: Pharma Mar, S.A. is a biopharmaceutical company focused on the research, development, production, and commercialization of bio-active principles for oncology across various international markets, with a market cap of €1.21 billion.

Operations: The company generates revenue primarily from its oncology segment, amounting to €194.09 million.

Insider Ownership: 11.8%

Earnings Growth Forecast: 55.1% p.a.

PharmaMar is poised for growth with its earnings expected to increase by 55.11% annually, outpacing the broader Spanish market. Despite a recent dip in net income to €3.54 million, positive clinical trial results for Zepzelca® could bolster future revenue streams. The company's forecasted high return on equity of 36.2% in three years and substantial insider ownership underline confidence in its long-term potential, though share price volatility remains a concern.

  • Click here and access our complete growth analysis report to understand the dynamics of Pharma Mar.
  • According our valuation report, there's an indication that Pharma Mar's share price might be on the cheaper side.
BME:PHM Ownership Breakdown as at Oct 2024

Will Semiconductor

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Will Semiconductor Co., Ltd. is a semiconductor design company offering sensor, analog, and touch screen and display solutions with a market cap of CN¥136.09 billion.

Operations: The company's revenue is generated from its sensor solutions, analog solutions, and touch screen and display solutions.

Insider Ownership: 30.7%

Earnings Growth Forecast: 38.9% p.a.

Will Semiconductor's recent earnings report highlights substantial growth, with net income rising to CNY 1.37 billion from CNY 153.12 million a year ago. Revenue also increased significantly, reaching CNY 12.09 billion for H1 2024. The company's earnings are forecasted to grow at an impressive rate of nearly 39% annually, outpacing the Chinese market average of about 24%. Despite no significant insider trading activity recently, high insider ownership suggests confidence in its growth trajectory.

  • Click here to discover the nuances of Will Semiconductor with our detailed analytical future growth report.
  • Our comprehensive valuation report raises the possibility that Will Semiconductor is priced higher than what may be justified by its financials.
SHSE:603501 Ownership Breakdown as at Oct 2024

International Games SystemLtd

Simply Wall St Growth Rating: ★★★★★☆

Overview: International Games System Co., Ltd. engages in the planning, design, research, development, manufacturing, marketing, servicing, and licensing of arcade, online, and mobile games primarily in Taiwan, the United Kingdom, and China with a market cap of NT$312.80 billion.

Operations: The company's revenue is primarily generated from its Online Games Division, contributing NT$8.99 billion, and its Business Game Division, which accounts for NT$7.13 billion.

Insider Ownership: 12.5%

Earnings Growth Forecast: 21.5% p.a.

International Games System Ltd. has demonstrated strong financial performance, with Q2 2024 sales reaching TWD 4.58 billion and net income rising to TWD 2.28 billion from the previous year. Its earnings are forecasted to grow significantly at over 21% annually, surpassing the Taiwan market average of approximately 19%. Recently added to the FTSE All-World Index, this inclusion reflects its growing prominence despite a highly volatile share price in recent months.

  • Get an in-depth perspective on International Games SystemLtd's performance by reading our analyst estimates report here.
  • According our valuation report, there's an indication that International Games SystemLtd's share price might be on the expensive side.
TPEX:3293 Ownership Breakdown as at Oct 2024

Turning Ideas Into Actions

  • Delve into our full catalog of 1486 Fast Growing Companies With High Insider Ownership here.
  • Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
  • Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Ready For A Different Approach?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include BME:PHM SHSE:603501 and TPEX:3293.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10